The LYCRA Company Announces Latest Higg Achievements
The LYCRA Company, a global leader in developing innovative fiber and technology solutions for the apparel and personal care industries, announced today that several of its manufacturing sites had their Higg Facility Environmental Module (Higg FEM) and Higg Facility Social & Labor Module (Higg FSLM) self-assessments verified by an independent third party last year and achieved scores in the top quartile.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230322005015/en/
The LYCRA Company’s manufacturing sites in Waynesboro, Virginia; Maydown, Northern Ireland; and Foshan, China, completed verification for the Higg FEM module, while its Tuas, Singapore, and Maydown sites completed verification for the Higg FSLM module.
The LYCRA Company’s manufacturing sites in Waynesboro, Virginia; Maydown, Northern Ireland; and Foshan, China, completed verification for the Higg FEM module, while its Tuas, Singapore, and Maydown sites completed verification for the Higg FSLM module. A copy of the verified reports for Higg FEM and Higg FSLM can be requested at communications@lycra.com.
Higg FEM reviews air emissions, energy use, environmental management systems, wastewater, waste, chemical management and water usage. The LYCRA Company’s six manufacturing sites have completed the self-assessment, with the three sites mentioned above securing verification. The company’s goal is to have sites representing 80% of LYCRA® fiber production to be Higg FEM verified by 2024.
“The LYCRA Company strives to be an industry leader for sustainability by utilizing credible and independently verified data,” said Alan McElreavey, operations sustainability program manager at The LYCRA Company. “The Higg Facilities modules are widely used within the apparel industry to assess the environmental impact of manufacturing facilities, to uncover opportunities for improvement, and to measure our progress against established baseline performance. Completing the Higg facility modules drives behaviors that become embedded in our company, enhancing our sustainability culture and creating measurable change.”
“Higg FEM is aligned with our goals in key impact areas and helps us improve our sustainability profile and operate as a good corporate citizen,” said Hector Chapa, Waynesboro site business integration manager. “It also supports two pillars of our Planet Agenda sustainability platform—corporate responsibility and manufacturing excellence.”
The LYCRA Company’s Tuas, Singapore and Maydown, Northern Ireland manufacturing sites also completed third-party verification of their Higg FSLM, both with scores in the top quartile. The Higg FSLM self-assessment provides insights into social progress and labor conditions at each site, including compensation and health and safety, and identifies areas for continuous improvement.
“Our upstream and downstream customers are increasingly asking suppliers like us to provide independent certifications that assess the environmental impact of their facilities, as well as social and labor practices in the workplace,” said Kok Beng Chew, Asia Pacific Regional Operations Director. “The Higg Facility Tools are a must-have for business today because they enable us to stay on track and be a responsible spandex producer.”
The LYCRA Company is a member of the Sustainable Apparel Coalition, a nonprofit alliance that developed the Higg Facility Tools. The global organization consists of over 280 stakeholders in the fashion industry.
To learn more about Higg assessments completed by The LYCRA Company, click here.
About The LYCRA Company
The LYCRA Company innovates and produces fiber and technology solutions for the apparel and personal care industries. Headquartered in Wilmington, Delaware, The LYCRA Company is recognized worldwide for its innovative products, technical expertise, sustainable solutions, and unmatched marketing support. The LYCRA Company owns leading consumer and trade brands: LYCRA®, LYCRA HyFit®, LYCRA® T400®, COOLMAX®, THERMOLITE®, ELASPAN®, SUPPLEX®, and TACTEL®. The LYCRA Company’s legacy stretches back to 1958 with the invention of the original spandex yarn, LYCRA® fiber. Today, The LYCRA Company focuses on adding value to its customers’ products by developing unique innovations designed to meet the consumer’s need for comfort and lasting performance. For more information, visit www.thelycracompany.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230322005015/en/
Contact information
Karie J. Ford
Karie.J.Ford@lycra.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
ReNAgade Therapeutics Continues Commitment to GanNA Bio and Glycan Biology27.4.2024 03:09:00 EEST | Press release
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the integration of key individuals of GanNA Bio into the ReNAgade ecosystem. GanNA founders Carolyn Bertozzi, Ph.D., and Richard D. Cummings, Ph.D, will now serve as advisors to ReNAgade. “ReNAgade will continue to benefit tremendously from GanNA’s promising work in developing extra-hepatic delivery technology that helps expand the breadth and potential of our own RNA medicines,” said Brian Goodman, Co-founder of ReNAgade. “Delivery is foundational to ReNAgade’s mission to overcome the current limitations of RNA medicines. We believe the technology developed within GanNA will help further solidify ReNAgade’s leadership position as we continue advancing our unique, integrated therapeutic platform.” Formed in 2021 and invested in by ReNAgade, GanNA Bio ha
HCLTech Reports FY24 Revenue of $13.3 Billion, up 5.4% YoY26.4.2024 23:06:00 EEST | Press release
HCLTech, a leading global technology company, today reported financial results for the fourth quarter and the full year ended March 31, 2024. The company reported full year revenue of $13.3 billion, up 5.4% YoY. Digital Services revenue grew by 5.3% (CC) and now contributes to 37.3% of IT Services revenue. HCLSoftware’s Annual Recurring Revenue came in at $1.02 billion. During FY24, the company won 73 large deals – 36 in Services and 37 in Software - that translated into TCV (new deal wins) of $9.76 billion, up 10% YoY. For the quarter, revenue came in at $3.43 billion, up 6% YoY. HCLTech won 21 large deals – 13 in Services and eight in Software, with a TCV of $2.29 billion during the quarter. In terms of geographies, Americas was the fastest growing region with 6.8% YoY (CC) growth followed by Europe, which grew by 5.5% YoY (CC). Industry vertical growth was led by Financial Services and Telecommunications, Media, Publishing & Entertainment. While Financial Services grew at 12.1% YoY
Kinaxis Positioned Highest on Ability to Execute in the Gartner® Magic Quadrant™ for Supply Chain Planning Solutions26.4.2024 19:03:00 EEST | Press release
Kinaxis® Inc. (TSX:KXS), a global leader in end-to-end supply chain orchestration, today announced it has been named a Leader in the 2024 Gartner® Magic Quadrant™ for Supply Chain Planning Solutions. Of the 20 vendors evaluated, Gartner positioned Kinaxis highest on Ability to Execute, marking the company’s 10th consecutive Leaders Quadrant within the report, a complimentary copy of which can be downloaded here. Kinaxis attributes its position to its patented concurrency approach and a proven track record of delivering innovative solutions against the foundation of its leading vision through the use of advanced technology such as AI, ML, and an intuitive user experience. Bolstered by a rich ecosystem of third-party implementation partners, Kinaxis continues to demonstrate that regardless of a customer’s industry, size, or maturity level, the company can be counted on to seamlessly orchestrate supply chain networks end-to-end from strategic planning to last-mile delivery. The recognitio
Vertex Announces European Commission Approval for KALYDECO® to Treat Infants With Cystic Fibrosis Ages 1 Month and Older26.4.2024 18:43:00 EEST | Press release
Vertex Pharmaceuticals (Nasdaq: VRTX) today announced that the European Commission has granted approval for the label expansion of KALYDECO® (ivacaftor) for the treatment of infants down to 1 month of age with cystic fibrosis (CF) who have one of the following mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene: R117H, G551D, G1244E, G1349D, G178R, G551S, S1251N, S1255P, S549N or S549R. “Today’s approval is an important milestone for the cystic fibrosis community. Treating CF early in life can potentially slow the progression of the disease, which is why it is so important to start treatment from a very young age,” said Carmen Bozic, M.D., Executive Vice President, Global Medicines Development and Medical Affairs, and Chief Medical Officer, Vertex. As a result of existing access agreements in Austria, Czech Republic, Denmark, Ireland, Norway, Sweden, and The Netherlands, eligible patients will have access to the expanded indication of KALYDECO® (ivacaftor)
Suzano 2023 annual report on Form 20-F26.4.2024 18:22:00 EEST | Press release
Suzano S.A. (B3: SUZB3 | NYSE: SUZ) informs that its 2023 Annual Report on Form 20-F was filed today with the U.S. Securities and Exchange Commission. Holders of the Company’s equity securities can receive hard copies of the Annual Report, including its audited financial statements, without charge by request directed to: ri@suzano.com.br. This document is also available on Suzano’s website (http://ir.suzano.com.br/). For further information, please contact our Investor Relations Department: Phone: (+55 11) 3503-9330 E-mail: ri@suzano.com.br View source version on businesswire.com: https://www.businesswire.com/news/home/20240426289818/en/ Contact information Hawthorn Advisors suzano@hawthornadvisors.com
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom